Opens in a new tab

Dr. Zheng Bin

Chinese name: 郑彬
Chief Physician, Director of Urology Center . Urology
Dr. Zheng Bin is a Chief Physician, Deputy Director of General Surgery and Director of the Urology Center and Lithotripsy Unit at Fosun Chancheng Hospital. An authority in minimally invasive stone treatment, he has performed over 200 da Vinci robot surgeries and about 3,000 inpatient operations a year.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

3,000+
Percutaneous nephrolithotomy (PCNL) procedures (cumulative)
5,000+
Flexible ureteroscopic holmium laser lithotripsy procedures (cumulative)
200+
Robotic-assisted grade-IV urologic procedures completed by his team

  • The Physician

About Dr. Zheng Bin

Dr. Zheng Bin is a Chief Physician at Fosun Chancheng Hospital, serving as Deputy Director of General Surgery and Director of the Urology Center and Lithotripsy Unit. A recognized authority on minimally invasive urinary stone treatment, he specializes in percutaneous nephrolithotomy for complex stones, flexible ureteroscopy with holmium laser, laparoscopic prostatectomy and bladder cancer surgery, and laser enucleation of the prostate. He has completed over 200 da Vinci robot-assisted surgeries and nearly 3,000 inpatient operations per year, and holds leadership roles in provincial and municipal urology societies.
1、Chief physician, Deputy Director of the Grand Surgery Department, Director of the Urology Center and Lithotripsy Room at Fosun Chancheng Hospital
2、Third-generation academic leader of the hospital’s renowned stone-treatment specialty, succeeding Li Dechao and Zhan Hejuan
3、Expert in minimally invasive treatment of complex kidney stones, including percutaneous nephrolithotomy and flexible ureteroscopic holmium laser lithotripsy
4、Skilled in laparoscopic radical prostatectomy and cystectomy, and transurethral laser enucleation of the prostate
5、Completed more than 200 da Vinci robot-assisted urological surgeries, with nearly 3,000 inpatient operations performed annually under his leadership
6、First author of studies in the China Journal of Endoscopy and Guangdong Medical Journal and corresponding author in the Chinese Journal of Endourology

Dr. Zheng Bin ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Complex kidney stones

As the third-generation leader of the hospital's renowned stone-treatment center, he performs percutaneous nephrolithotomy (PCNL) using advanced imaging guidance and precise puncture technique for complex and staghorn kidney stones, achieving high stone-free rates with minimal blood loss and quick recovery.

Upper urinary tract stones

He uses flexible ureteroscopy with holmium laser lithotripsy for even hard or impacted stones to treat ureteral and renal stones, fragmenting stones precisely and removing fragments completely through natural passages, avoiding open surgery and enabling patients to recover rapidly and fully.

Prostate and bladder cancer

He performs laparoscopic radical prostatectomy and radical cystectomy for prostate and bladder cancer within a comprehensive treatment plan, combining minimally invasive technique with oncological precision to remove tumors completely and preserve urinary function and patients' quality of life as much as possible.

More: benign prostatic hyperplasia laser enucleation——minimally invasive relief of urinary obstruction; minimally invasive urologic tumor treatment——laparoscopic and endoscopic tumor removal; male reproductive health——diagnosis and treatment of andrological disorders

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Minimally Invasive Percutaneous Nephrolithotomy versus Open Surgery for Staghorn Kidney Stones
This comparative study evaluated minimally invasive percutaneous nephrolithotomy (MPCNL) against open surgery in 142 patients with complex staghorn kidney stones. MPCNL achieved a higher stone-free rate, shorter hospital stay and less blood loss, confirming it as a safe, effective treatment for patients seeking minimally invasive kidney stone surgery in Foshan and across Guangdong.
2. Single-Tract Percutaneous Nephrolithotomy via the Posterior Middle Calyx for Renal Cast Stones
Published in Guangdong Medical Journal, this clinical report describes a single-tract percutaneous nephrolithotomy technique performed through the posterior middle calyx to treat renal cast (staghorn) stones. The minimally invasive approach improved stone clearance and reduced trauma, offering a reliable option for patients with complex kidney stones in Foshan, Guangdong.
3. Percutaneous Nephrolithotomy Combined with Flexible Ureteroscopy for Complex Renal Stones in the Elderly
This retrospective study compared single-tract percutaneous nephrolithotomy combined with flexible ureteroscopy against standard multi-channel PCNL in 118 elderly patients with complex kidney stones. The combined minimally invasive method shortened operating time and hospital stay, reduced bleeding and complications, and better protected kidney function in older patients.
4. Minimally Invasive Treatment of Upper Ureteral Stones with Mild-to-Moderate Hydronephrosis (386 Cases)
Analyzing 386 patients, this study compared extracorporeal shockwave lithotripsy, ureteroscopic lithotripsy and minimally invasive percutaneous nephrolithotomy for upper ureteral stones with mild-to-moderate hydronephrosis. The authors concluded that MPCNL and combined ureteroscopic approaches were highly effective and safe, guiding treatment choices for patients with ureteral stones and kidney swelling.
5. Robotic Single-Position Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Led by Dr. Zheng Bin, the urology team at Foshan Fosun Chancheng Hospital developed a robotic single-position nephroureterectomy for upper urinary tract urothelial carcinoma. This signature minimally invasive technique, presented at the 2025 National Annual Meeting, reduces repositioning and improves surgical precision for patients with upper urinary tract tumors.
6. Robotic Radical Prostatectomy with Extended Pelvic Lymph Node Dissection for High-Risk Prostate Cancer
At the 2025 Guangdong Prostate Cancer Integrated Diagnosis and Treatment Forum, Dr. Zheng Bin shared his preliminary experience with extended pelvic lymph node dissection during robotic radical prostatectomy for high-risk prostate cancer. The report highlighted individualized dissection ranges to improve outcomes for men with high-risk prostate cancer.
  • Affiliated Hospital

Where Dr. Zheng Bin practices

Foshan

Foshan Fosun Chancheng Hospital

Chinese name: 佛山复星禅诚医院
Foshan Fosun Chancheng Hospital, a Grade-A tertiary flagship of Fosun Group since 1958, is renowned for its 'three treasures' of spine orthopedics, urology and Women & Children Center, backed by JCI accreditation and serving 3.19 million outpatient visits a year.
Since 1958
68 years of care
1,750
Licensed beds
3.19 million
Annual outpatient visits
7th Edition
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zheng Bin?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zheng Bin.